Do you have the same question? Follow this Question
Dec 04, 2025 - 01:44 PM
We’ve provided several answers to questions related to Lenvima (lenvatinib) , see some other helpful Q&A related to this product.
Question: What should pregnant women know about this medication?
Answer: Pregnant women should only use this medication if their doctor approves it, as there is potential risk to the unborn baby. Understanding this risk is crucial for making informed decisions about cancer treatment during pregnancy.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is Lenvatinib. Lenvatinib is a targeted therapy that blocks certain proteins on cancer cells, which helps stop tumors from growing and spreading. This targeted approach can offer more effective treatment for some cancer patients.
